Eric Aguiar's Net Worth
$3.12 Million
Who is Eric Aguiar?
Eric Aguiar has an estimated net worth of $3.12 Million. This is based on reported shares across multiple companies, which include Invitae Corp, Biohaven Pharmaceutical Holding Co Ltd., BridgeBio Pharma, Inc., HEALTHCARE ACQUISITION CORP, REPLIDYNE INC, Eidos Therapeutics, Inc., Biomea Fusion, Inc., CRITICAL THERAPEUTICS INC, Ocera Therapeutics, Inc., ADVANCIS PHARMACEUTICAL CORP, and ACTIVBIOTICS INC.
SEC CIK
Eric Aguiar's CIK is 0001262325
Past Insider Trading and Trends
2020 was Eric Aguiar's most active year for acquiring shares with 9 total transactions. Eric Aguiar's most active month to acquire stocks was the month of March. 2020 was Eric Aguiar's most active year for disposing of shares, totalling 13 transactions. Eric Aguiar's most active month to dispose stocks was the month of October. 2020 saw Eric Aguiar paying a total of $889,300.00 for 233,950 shares, this is the most they've acquired in one year. In 2020 Eric Aguiar cashed out on 160,000 shares for a total of $3,937,267.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HEALTHCARE ACQUISITION CORP (ALT) Snapshot price: $6.21
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,537.74% | 3.17M |
$7.66 | $957,500.00 | 3.3M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
REPLIDYNE INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +710.86% | 3.17M |
—
|
—
| 3.61M |
Jul 3
| |||
Form 4
| +1,069.02% | 3.17M |
—
|
—
| 3.46M |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CRITICAL THERAPEUTICS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 4.06M |
$7.00 | $2,499,700.00 | 4.06M |
Mar 5 - Jun 2
| |||
Form 4
|
∞
| 4.06M |
$7.00 | $2,499,700.00 | 4.06M |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ADVANCIS PHARMACEUTICAL CORP No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.34% | 682.9K |
$2.36 | $1,614,177.82 | 6.22M |
Apr 12
| |||
Form 4
|
∞
| 5.53M |
—
|
—
| 5.53M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACTIVBIOTICS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,537.74% | 3.17M |
$7.66 | $957,500.00 | 3.3M |
Aug 3
| |||
No matching records found |